Hepatic Cells via Cava Vein Can Influence Allogenic Islet Rat Transplantation

• Published in: Cell transplantation Vol. 12; no. 8; pp. 891 - 896
• Main Authors: Jara-Albarrán, Antonino, Soto-Montenegro, M. Luisa, Zugasti, Ana, Rollán, Eduardo, Alvarez, Ysmael, Alvarez, Granada
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.11.2003; SAGE Publishing
• Subjects: Animals; Blood Glucose - metabolism; Cell Transplantation; Graft Survival; Hepatocytes - cytology; Hepatocytes - metabolism; Islets of Langerhans - cytology; Islets of Langerhans - metabolism; Islets of Langerhans Transplantation; Liver - blood supply; Male; Portal Vein; Rats; Rats, Wistar; Transplantation, Homologous; Venae Cavae; Rats; Islet allografts; Cotransplantation; Hepatic cells
• ISSN: 0963-6897; 1555-3892
• DOI: 10.3727/000000003771000129

We have reported, previously, some effect of allogenic hepatic cells for islet tolerance when they are injected mixed (hepatic cells and islets) in different proportions via portal vein, in diabetic Wistar rats. Now we have studied the role of allogenic hepatic cells injected sequentially 15 min before islets, comparing via the portal vein (A and B groups) and via the cava vein (C and D groups) with a control group of islets alone. The allogenic islets were always injected via portal vein, in similar conditions, while the ratio of hepatic cells/islets was 100:1 (A, C groups) or 200:1 (B, D groups). Islets and hepatic cells were obtained from several different rats. The transplanted rats were observed during 30 days and results compared among the different rat groups: porta-porta (P/P), cava-porta (C/P), and control group. Statistically, a significant interaction between type of transplant and proportion of hepatic cells was observed. Also, C plus D groups showed statistical difference with the control group (p < 0.017) and also all the groups together (p < 0.047). These results suggest that hepatic cells can induce, in some cases, islet graft prolongation in Wistar rats. Better results were obtained when hepatic cells were injected via the cava vein than via the portal vein. Because we used a liver cell suspension integrated for several kinds of cells, the study does not clarify if this effect can be related to some specific hepatic cell subpopulation. To confirm the results and to determine if the hypothetical mechanism can be attributed to a block of the immune system or to some factor secreted by hepatic cells, more studies must be performed.